MiNK Therapeutics, Inc.INKTNASDAQ
Loading
PB Ratio: Premium ValuationElevated
Percentile Rank80
Studio
Year-over-Year Change

Price-to-book ratio

Percentile
P80
Within normal range
vs 3Y Ago
-0.2x
Contraction
Streak
2 yr
Consecutive growthElevated
PeriodValueYoY Change
2024-1.33+34.6%
2023-2.04+99.1%
2022-219.00-3587.6%
20216.28+185.2%
2020-7.37+7.3%
2019-7.95-